Science & Enterprise subscription

Follow us on Twitter

  • Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as w… https://t.co/XDS3u9zDEX
    about 17 hours ago
  • New post on Science and Enterprise: MIT Spins-Off 32 Start-Ups in 2018 https://t.co/MwJpYlGhwV #Science #Business #AAASmtg
    about 17 hours ago
  • New contributed post on Science and Enterprise: https://t.co/MCiZyaoc0I Ships Are Becoming Safer With Technology
    about 20 hours ago
  • A panel of data and behavioral scientists envision great potential for blockchain in science, but show few cases o… https://t.co/Ch0yJRek4W
    about 2 days ago
  • New post on Science and Enterprise: Blockchain and Science, Not Ready for Prime Time https://t.co/mYiRQ0j8vU #Science #Business #AAASmtg
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Designing Strawberry Varieties for Japanese Farms

Strawberries

An agricultural genomics company in Israel and auto maker Toyota began a joint project to design new varieties of strawberries to grow on Japanese farms . . . → Read More: Designing Strawberry Varieties for Japanese Farms

Robotics, A.I. Employed for Personal Autism Therapy

Nao robot

An engineering lab at MIT developed techniques for combining robotics with deep learning, a form of artificial intelligence, to personalize autism therapy. . . . → Read More: Robotics, A.I. Employed for Personal Autism Therapy

Large-Scale Process Devised for Lab-Made Liver Tissue

Researchers in Japan and the U.S. created techniques for producing liver tissue in large quantities in the lab for transplant or drug testing. . . . → Read More: Large-Scale Process Devised for Lab-Made Liver Tissue

Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies. . . . → Read More: Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Takeda, Biosurfaces Partner on Nanofiber Devices

Takeda Pharmaceutical Company is joining with a developer of medical devices from nanoscale bioactive fibers to design new devices for gastrointestinal, or GI, disorders. . . . → Read More: Takeda, Biosurfaces Partner on Nanofiber Devices

Liquid Biopsy Company Gains $360M for Cancer Sequencing

A company using blood tests to diagnose cancer is receiving a $360 million investment for its campaign to sequence DNA from 1 million people at high risk of cancer. . . . → Read More: Liquid Biopsy Company Gains $360M for Cancer Sequencing

Grid Computing Harnessed for Childhood Cancer Research

An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children. . . . → Read More: Grid Computing Harnessed for Childhood Cancer Research

Biotech, Pharma Partner on Neuro Drug Discovery

A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders. . . . → Read More: Biotech, Pharma Partner on Neuro Drug Discovery

Stem Cell Therapy Company Formed, Staked to $225M

A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells. . . . → Read More: Stem Cell Therapy Company Formed, Staked to $225M

Ostrich Antibodies to Fight Resistant Infections

A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals. . . . → Read More: Ostrich Antibodies to Fight Resistant Infections